DANAHER (DAP MU) stock market data APIs
€206.0532
0(0%)
as of January 16, 2026
Try our APIs with
free plan!
DANAHER Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for DAP.MU.
Prev. Close
206.0532
Open
206.0532
High
206.0532
Low
206.0532
52 wk Range
149.4343-239.4313
Market Cap
200 886 M
Dividends (Yield)
0.0039
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get DANAHER data using free add-ons & libraries
Get DANAHER Fundamental Data
DANAHER Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
DANAHER News
New
Danaher Corporation (DHR) Maintains Buy Rating as Analysts See Upside in 2026
We recently compiled a list of the 10 Best Investments During A Recession. Danaher Corporation is placed third among the best investments. TheFly reported on January 7 that TD Cowen raised its price ...
Health Care Roundup: Market Talk
Find insight on GLP-1 medications, Danaher and more in the latest Market Talks covering Health Care. Continue Reading
How Investors Are Reacting To Danaher (DHR) Upbeat 2025 Outlook And Growing Synthetic Biology Ambitions
In early January 2026, Danaher announced ahead of the J.P. Morgan Healthcare Conference that it expects fourth-quarter 2025 revenue and full-year non-GAAP adjusted diluted EPS to finish toward the upp...
Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies’ Clonal DNA and XL Clonal DNA Products
Integrated DNA Technologies and Ansa Biotechnologies announced a new collaboration to enable researchers to design and assemble longer, more complex constructs, delivering a new standard for speed, pr...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
